China SXT Pharmaceuticals, Inc.

1.3200+0.06 (+4.76%)
Oct 28, 4:00:00 PM EDT · NasdaqCM · SXTC · USD

Upcoming Earnings

Report date
≈ -

Key Stats

Market Cap
153.16M
P/E (TTM)
-
Basic EPS (TTM)
-2.43
Dividend Yield
0%

About

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.

CEO
Mr. Feng Zhou
IPO
1/4/2019
Employees
75
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic